Company / CapEx per Share
Compass Therapeutics, Inc. CapEx per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.02
FY2020-FY2024
Trend
+35.9%
vs FY2023
Sector context
#179 of 190
Health Care
What the data says
Among 190 Health Care companies, Compass Therapeutics, Inc. is in the bottom 6% for capex per share. CapEx per Share returned to growth in FY2024 after 2 years of decline, reaching $0.00.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -65.9%.
Declined from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -76.6%
- 5-Year CAGR
- -65.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 190This company $0.00 Sector average $2.49
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, capex per share increased 35.9% year-over-year.
- Ranks #179 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | +35.9% |
| FY2023 | $0.00 | -86.0% |
| FY2022 | $0.00 | -93.3% |
| FY2021 | $0.02 | +624.1% |
| FY2020 | $0.00 | -95.1% |
| FY2019 | $0.07 | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026